Cargando…
Aldehyde dehydrogenase 2 polymorphism is associated with chemotherapy‐related cognitive impairment in patients with breast cancer who receive chemotherapy
BACKGROUND: Chemotherapy‐related cognitive impairment (CRCI) is a common but easily overlooked condition that markedly affects the quality of life (QOL) of patients with breast cancer. The rs671 is a common gene polymorphism of aldehyde dehydrogenase 2 (ALDH2) in Asia that is involved in aldehyde me...
Autores principales: | Yao, Senbang, Li, Wen, Liu, Shaochun, Cai, Yinlian, Zhang, Qianqian, Tang, Lingxue, Yu, Sheng, Jing, Yanyan, Yin, Xiangxiang, Cheng, Huaidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028021/ https://www.ncbi.nlm.nih.gov/pubmed/36200595 http://dx.doi.org/10.1002/cam4.5319 |
Ejemplares similares
-
Managing Cancer and Living Meaningfully (CALM) alleviates chemotherapy related cognitive impairment (CRCI) in breast cancer survivors: A pilot study based on resting‐state fMRI
por: Yao, Senbang, et al.
Publicado: (2023) -
The Managing Cancer and Living Meaningfully (CALM) Intervention Alleviates Chemotherapy-Related Cognitive Impairment in Patients with Breast Cancer by Modulating Pan-Immune-Inflammation Values
por: Yao, Senbang, et al.
Publicado: (2022) -
The correlation between neutrophil-to-lymphocyte ratio, carcinoembryonic antigen, and carbohydrate antigen 153 levels with chemotherapy-related cognitive impairment in early-stage breast cancer patients
por: Yu, Sheng, et al.
Publicado: (2022) -
Comprehensive Analysis of Aldehyde Dehydrogenases (ALDHs) and Its Significant Role in Hepatocellular Carcinoma
por: Yao, Senbang, et al.
Publicado: (2021) -
Identification of hub genes related to CD4(+) memory T cell infiltration with gene co-expression network predicts prognosis and immunotherapy effect in colon adenocarcinoma
por: Tang, Lingxue, et al.
Publicado: (2022)